Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses

Trulieve (OTCQX: TCNNF) filed applications with the U.S. Drug Enforcement Administration to register certain state‑licensed medical marijuana operations under the expedited pathway opened by rescheduling medical marijuana to Schedule III.

Rhea-AI Summary

Trulieve (OTCQX: TCNNF) filed applications with the U.S. Drug Enforcement Administration to register certain state‑licensed medical marijuana operations under the expedited pathway opened by rescheduling medical marijuana to Schedule III.

For applications submitted within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana is deemed approved unless the DEA notifies otherwise. Trulieve says it operates over 200 dispensaries serving only medical patients.

Positive

• Filed DEA applications for state‑licensed medical marijuana operations
• Potential licensure to manufacture, distribute, and dispense Schedule III products
• Operates over 200 dispensaries serving medical patients

Negative

• Deemed approvals are conditional — valid only "unless otherwise notified" by DEA
• Registration applies to state‑licensed medical businesses only, not recreational operations

Argus Apr 29 session

-4.17% close to close Open Argus

Details

News Market Reaction – TCNNF

On Apr 29, the day this news came out, TCNNF closed 4.17% below the previous close.

Data tracked by StockTitan Argus for the Apr 29 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TALLAHASSEE, Fla., April 29, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state‑licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.

"DEA registration for our medical business marks a historic step forward for Trulieve and the patients we serve," said Trulieve Chief Executive Officer Kim Rivers. "With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis."

Following the reclassification of medical marijuana to Schedule III, the DEA established an expedited registration process for eligible state‑licensed medical marijuana operators. For operators that apply within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana products is deemed approved unless otherwise notified.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by cornerstone markets in Arizona, Florida, Ohio, and Pennsylvania. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve   
Instagram: @Trulieve
X: @Trulieve

Investor and Media Contact
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-applications-filed-for-dea-registration-of-state-licensed-medical-marijuana-businesses-302757853.html

SOURCE Trulieve Cannabis Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Trulieve (TCNNF) file with the DEA on April 29, 2026?

Trulieve filed applications to register certain state‑licensed medical marijuana operations with the DEA. According to Trulieve, the filings seek expedited Schedule III registration after medical marijuana was rescheduled.

Does Trulieve's DEA filing mean immediate federal approval for TCNNF medical operations?

Not immediately — approvals are deemed effective only if the DEA does not notify otherwise. According to Trulieve, applications filed within 60 days are deemed approved unless the DEA issues a different notice.

What activities would DEA registration allow Trulieve (TCNNF) to perform?

DEA registration would allow Trulieve to manufacture, distribute, and dispense Schedule III medical marijuana products. According to Trulieve, the expedited pathway covers those licensure categories for eligible state‑licensed operators.

How many dispensaries does Trulieve say could be affected by the DEA registration?

Trulieve states it operates over 200 dispensaries serving only medical patients. According to Trulieve, that footprint positions the company to pursue registration under the expedited Schedule III process.

Is the DEA expedited registration pathway time‑limited for companies like Trulieve (TCNNF)?

Yes — the expedited process references a 60‑day application window for deemed approvals. According to Trulieve, operators applying within 60 days are deemed approved unless otherwise notified by the DEA.

Will DEA registration for Trulieve (TCNNF) cover recreational cannabis operations?

No — the filings relate to state‑licensed medical marijuana operations only. According to Trulieve, the expedited Schedule III registration pathway applies specifically to medical operators.